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ABSTRACT
Background: The association of body mass index (BMI) with risks of ischemic stroke subtypes have not been established.
Methods: Cumulative average BMI was calculated using self-reported body weight and height obtained from baseline (Cohort I
in 1990, and Cohort II from 1993–1994) and 5- and 10-year questionnaire surveys of Japan Public Health Center-based
prospective (JPHC) study. A total of 42,343 men and 46,413 women aged 40–69 years were followed-up for the incidence of
lacunar, large-artery occlusive, and cardioembolic strokes. A sub-distribution hazard model was used to estimate sub-
distribution hazard ratios (SHRs) and the 95% conﬁdence intervals (CIs).
Results: During a median of 20.0 years of follow-up, we documented 809 and 481 lacunar, 395 and 218 large-artery occlusive,
and 568 and 298 cardioembolic strokes in men and women, respectively. After adjustment for baseline age, updated smoking,
alcohol consumption, leisure-time physical activity, and histories of hypertension, dyslipidemia, and diabetes mellitus,
cumulative average BMI was positively linearly associated with lacunar (trend P = 0.007), large-artery occlusive (trend
P = 0.002), and cardioembolic (trend P < 0.001) strokes in men, and with lacunar (trend P < 0.001) and large-artery occlusive
(trend P = 0.003) strokes in women. There were approximately two-fold excess risk of cardioembolic stroke in both sexes and of
lacunar and large-artery occlusive strokes in women for cumulative average BMI ≥30 kg=m2 compared to BMI 23–<25kg=m2.
Conclusion: Cumulative average BMI showed a positive linear eﬀect on sub-distribution hazards of lacunar, large-artery
occlusive, and cardioembolic strokes in both sexes, except for cardioembolic stroke in women.
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INTRODUCTION
Ischemic stroke is one of the leading causes of long-term
disability and mortality worldwide.1 Increased risk of ischemic
stroke by excessive adiposity has been observed in diverse
populations,2–4 but its associations with ischemic stroke subtypes
(eg, lacunar, large-artery occlusive, and cardioembolic strokes)
were examined only in a few studies5,6 and have not been
established. One study in American communities (n = 13,549,
baseline year: 1987)5 reported linear and positive associations of
BMI with all ischemic stroke subtypes, which was totally
explained by known risk factors (eg, blood pressure, diabetes,
and high density lipoprotein cholesterol). Another study in Japan
(n = 1,621, baseline year: 1961) did not ﬁnd any associations
except for a positive association between BMI and lacunar stroke
in women, which was independent of known risk factors,
including systolic blood pressure.6 One explanation for the
discrepancies might be that the mean BMIs and the compositions
of ischemic stroke subtypes diﬀer considerably between the two
populations.7–9 However, it might also be due to diﬀerences in the
way BMI was modeled: baseline only in the former5 versus
updated as time-dependent covariate in the latter.6 BMI used in
the latter study would mainly reﬂect a short-term eﬀect of the
exposure since BMI obtained in the nearest examinations before
the events of cerebral infarction was related to the outcome. This
might be appropriate for an exposure like blood pressure, which
would elevate generally with advancing age, but might not be for
an exposure like BMI, which would change in diﬀerent directions
with aging. Instead, we deﬁned cumulative index of BMI as
a kind of time-dependent exposure in the present study since
potential eﬀect of BMI on the outcome would require longer time.
Nevertheless, we carried out baseline BMI only or updated BMI
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analyses to facilitate comparisons among studies. Since
cumulative average BMI was regarded to capture the average
level of exposure over longer-term than a single measurement,
such as baseline (long latent period) or update (short latent
period), yielding useful information for prevention, the analysis
using cumulative average BMI was considered as the main one.
Furthermore, we could not readily assume that similar
observation would be made even if another study was conducted
in Japan employing similar methodological approaches, since the
mean BMI increased from 21.7 to 23.3 from 1960 to 1990 in men
aged 50–59 in Japan.10,11 It would be more relevant to examine
the association in a more contemporary cohort. In the present
study, we examined the associations of BMI with ischemic stroke
subtypes in a Japanese representative and more recent cohort.
Since hypertension is the most signiﬁcant risk factor for ischemic
stroke, the stratiﬁed analysis by hypertension was also conducted
to examine the possible eﬀect modiﬁcation.
METHODS
Population
The Japan Public Health Center-based prospective (JPHC) study
was established in 1990 (Cohort I) and 1993–1994 (Cohort II)
based on resident registry of 29 districts under 11 public health-
center areas throughout Japan.12,13 Of 140,420 individuals
enrolled (Cohort I, n = 61,595; Cohort II, n = 78,825), two
public health-center areas without data on cardiovascular disease
incidence (n = 23,524), individuals not in the target age range
(Cohort I: 40–59 years, Cohort II: 40–69 years), non-Japanese,
and those who moved out before baseline survey (n = 552) were
excluded from the present analysis. A self-administered ques-
tionnaire regarding height, body weight, lifestyles, and medical
histories was distributed to all participants at baseline and
returned from 43,130 subjects in Cohort I and 51,948 in Cohort
II. Subjects with missing information on height or body weight
(n = 1,067); smoking, alcohol consumption, leisure-time physical
activity, histories of hypertension, dyslipidemia, or diabetes
mellitus (n = 1,753); as well as those who reported histories of
cardiovascular disease or cancer (n = 3,502) at baseline were
further excluded, leaving 42,343 men and 46,413 women (Cohort
I: 40,563; Cohort II: 48,193) for the analysis. The study protocol
of the JPHC study, was approved by the Human Ethics Review
Committees of the National Cancer Center (13-021), Osaka
University (14285-4), and Fujita Health University (HM15-255).
Measurements of covariates
Follow-up questionnaire surveys were conducted at 5 and 10 years
to update height, body weight, lifestyles, and medical histories.
BMI was calculated as body weight (kg) divided by squared
height (m2). The validity of self-report was examined in the JPHC
Study participants (Cohort I) for whom health check-up data were
available.14 Namely, the self-reported BMIs (mean: 23.45 in men
and 23.57 in women) were slightly lower than measured BMIs
(mean: 23.54 in men and 23.78 in women), and the Spearman
correlation coeﬃcients were 0.89 in men and 0.91 in women in
the self-reported BMI range from 14 to 40 kg=m2. Smoking was
categorized into never-smoker, ex-smoker, current smoker of <20
cigarettes=day, and current smoker of≥20 cigarettes=day. Alcohol
consumption habit was evaluated as the weekly consumption by
multiplying weekly frequency and the amount of ﬁve speciﬁc
alcoholic beverages taken on each occasion, which was grouped
into never-drinker, former-drinker, and current drinker of <150
g=week, current drinker of 150–<300 g=week, and current drinker
of ≥300 g=week. The frequency of leisure-time physical activity
was assessed as none, 1–3 times=month, 1–2 times=week, 3–4
times=week, and almost everyday. Histories of hypertension,
dyslipidemia, or diabetes mellitus were deﬁned using the self-
report of previous diagnoses or current use of medications, as well
as by physical and laboratory data for those with blood pressure,
total cholesterol, and casual glucose measurements at baseline
(n = 32,292, 32,289, and 21,871 subjects, respectively) using
the following criteria: systolic blood pressure ≥140mmHg or
diastolic blood pressure ≥90mmHg; total cholesterol ≥240
mg=dL; and blood glucose ≥126mg=dL for those fasting more
than 8 hours (otherwise ≥200mg=dL).
Ascertainment of ischemic stroke event
All the major hospitals capable of managing acute stroke
care located in the sampling areas of the study were registered.
The medical records were reviewed regularly by physicians in
registered hospital or public health center blinded to the risk
factor statuses, using the standard format of registry. To complete
surveillance for incidence of fatal stroke, a systematic review of
death certiﬁcate was conducted. The stroke diagnosis and the
incidence date was assigned according to criteria adopted from
the National Survey of Stroke criteria, which require a con-
stellation of neurological deﬁcits of sudden or rapid onset lasting
at least 24 hours or until death.15,16 A stroke was classiﬁed as
ischemic stroke when acute infarction appeared on the computed
tomography scans or magnetic resonance images, or documented
in the autopsy report, and no evidence for intracerebral or
subarachnoid hemorrhage. Ischemic stroke was further classiﬁed
into lacunar, large-artery occlusive, and cardioembolic stroke. A
stroke was classiﬁed as lacunar according to the location (basal
ganglia, brain stem, thalamus, internal capsule, or cerebral white
matter) of the infarct. Deﬁnition of large-artery occlusive stroke
was deﬁned as infarct involving cortical areas. Cardioembolic
stroke depended on clinical diagnosis with the presence of an
embolus in the brain or medical record evidence of a possible
source of embolus such as moderate or more severe valvular heart
disease, atrial ﬁbrillation, or intracardiac thrombus. Undetermined
ischemic stroke included all ischemic strokes that could not be
classiﬁed into lacunar, large-artery occlusive, or cardioembolic
stroke (n = 82 in men and n = 127 in women). They were
censored at the time of onset and were not analyzed in relation to
BMI in the present study. However, we conducted sensitivity
analyses that regarded these undetermined events as lacunar,
large-artery occlusive, or cardioembolic stroke. A focal neuro-
logical deﬁcit lasting <24 hours (ie, transient ischemic attack) and
asymptomatic lacunar stroke were not systemically ascertained
and, thus, were not included. The reliability of the same coding
system was evaluated in a diﬀerent study.16
Follow-up
Subjects were followed-up from the date of the baseline survey
(cohort I in 1990, and cohort II 1993 to 1994) until ﬁrst incidence
of stroke regardless of the subtypes, death, moving out of study
area, or the end of 2012, whichever came ﬁrst. Residence and
survival were ascertained annually using residential registries
maintained by each municipality. In Japan, residency and death
registration are required by law, and these registries are believed
to be complete. Participants who moved out from their original
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residential areas were identiﬁed in each area and treated as
censored at that time. Information on the cause of death was
obtained through the death certiﬁcate provided by the Ministry of
Health, Labor, and Welfare after the Ministry of Internal Aﬀairs
and Communications granted permission.
Statistical analysis
Men and women were analyzed separately. The exposure variable
(BMI) was treated in the analyses in three diﬀerent ways. First,
baseline BMI and covariates were used. Second, BMI was updated
at 5- and 10-year follow-up. The covariates were also updated as
time-dependent variables in the statistical models. Third, as the
main analysis, cumulative average BMI was calculated for each
subject using values in each 5-year interval questionnaire survey.
Namely, it was deﬁned as the values at baseline for those followed
up for less than 5 years, as the mean of baseline and 5-year survey
for those followed-up for 5 years or more but less than 10 years,
and as the mean of baseline, 5-, and 10-year surveys for those
followed for more than 10 years. Cumulative averages of
numerical covariates were created in the same fashion. Categorical
variables were simply updated to newer values. For those who
were followed up for 5 years or more or 10 years or more but
without 5-year or 10-year questionnaire data on those variables,
the missing values were imputed using the last-observation carried
forward method.
For all the BMI variables, they were divided into seven
categories, <19, 19–<21, 21–<23, 23–<25, 25–<27, 27–<30,
≥30 kg=m2, with 23–<25 kg=m2 as the reference (a category
which contains the mean BMI for men [23.5 kg=m2] and women
[23.6 kg=m2]).
Since subjects who died would have no probability of experi-
encing incidence in the future, treating them as non-informative
censoring would inﬂate the estimate of cumulative incidence. The
magnitude of inﬂation in the incidence would be greater in
categories with higher mortality rates (ie, in low and high BMI
categories than in the reference one), resulting in overestimation of
relative risks. Thus, deaths from causes other than ischemic stroke,
as well as those from undetermined subtype of ischemic stroke,
were considered as competing events in the present study. Fine and
Gray’s sub-distribution hazard model was used to estimate sub-
distribution hazard ratios (SHRs) and 95% conﬁdence intervals
(CIs).17,18 Three statistical models were performed stratiﬁed by 9
public health centers. Multivariable model 1 adjusted for baseline
age (5-year categories from 40–44 to 65–69 years). Multivariable
model 2 adjusted further for smoking, alcohol consumption, and
leisure-time physical activity. Multivariable model 3 adjusted
further for histories of hypertension, dyslipidemia, and diabetes
mellitus. The SHR from Fine and Gray’s model denotes the
magnitude of the relative change in the sub-distribution hazard
function associated with one unit change in the given covariate.17
Positive SHR denoted as X can be interpreted as evidence that one
unit increase in a coeﬃcient is associated with a (X − 1) + 100%
increase in the rate of an event of the interest in subjects who are
either event-free or who have experienced a competing event. We
described SHRs greater and smaller than unity (1) as increased
and decreased SHR, respectively, in this study.
The stratiﬁed analysis by the history of hypertension, either at
baseline, 5 years, or 10 years was done in multivariable model 3.
Interaction of hypertension with BMI categories was tested.
For the updated BMI analyses, a time-dependent Cox pro-
portional hazard model19 stratiﬁed by 9 public health centers was
used to estimate hazard ratios (HRs) and 95% CIs for incidence
occurred between each 5-year questionnaire cycle, after adjusting
for time-dependent covariates.
Test of linear trend was performed by assigning median BMI
values for all subjects in each BMI category and by treating it
as a continuous variable. Test of quadratic trend was done by
assigning squared values of median BMI.
All analyses were conducted using SAS for Windows, version
9.4 (SAS=STAT 13.1) (SAS Institute, Cary, NC, USA).
RESULTS
Higher cumulative average BMI was associated with younger
age in men but older age in women (Table 1). Current smoking
was associated with lower cumulative average BMI in men. The
prevalence of hypertension, hyperlipidemia, and diabetes were
higher in men and women with higher categories of cumulative
average BMI.
During a median of 20.0 years of follow-up, 809 and 481
lacunar, 395 and 218 large-artery occlusive, and 568 and 298
cardioembolic strokes were documented in men and women,
respectively. Even in the fully-adjusted model that included
known mediators, categories of cumulative average BMI were
linearly positively associated with all the ischemic stroke sub-
types in both sexes (all trend P < 0.05), except for cardioembolic
stroke in women (trend P = 0.14) (Table 2). Relative to men
with BMI of 23–<25 kg=m2, SHRs of lacunar and large-artery
occlusive stroke were signiﬁcantly lower in those with cumulative
average BMI of <19 kg=m2 (SHR 0.62; 95% CI, 0.40–0.96; and
SHR 0.32; 95% CI, 0.15–0.70, respectively). We observed the
signiﬁcantly increased SHR of cardioembolic stroke in men
whose cumulative average BMI was ≥30 kg=m2 (SHR 2.14; 95%
CI, 1.34–3.41), and that of lacunar stroke in women whose
cumulative average BMI were 27–<30 and ≥30 kg=m2 (SHR
1.40; 95% CI, 1.05–1.87 and SHR 1.77; 95% CI, 1.19–2.63,
respectively). Similarly, women with cumulative average BMI of
≥30 kg=m2 had increased SHRs of large-artery occlusive and
cardioembolic strokes (SHR 1.90; 95% CI, 1.07–3.37 and SHR
1.89; 95% CI, 1.15–3.11, respectively).
The stratiﬁed analysis by hypertension indicated similar
associations of cumulative average BMI with risk of lacunar
and cardioembolic stroke regardless of hypertension status in
both men and women (P for interaction > 0.10 in both men and
women) (Table 3). However, the positive association of BMI
with risk of large-artery occlusive stroke was not observed in
men with hypertension and in women without hypertension (P for
interaction = 0.01 in men, and 0.08 in women).
The analyses that used baseline BMI yielded generally similar
but slightly attenuated results, except for its association with
cardioembolic stroke in women (eTable 1). The SHRs of baseline
BMI ≥30 kg=m2 as well as of lower BMI categories for
cardioembolic stroke in women were signiﬁcant (BMI ≥30
kg=m2, SHR 2.55; 95% CI, 1.56–4.19; BMI 19–<21kg=m2, SHR
1.56; 95% CI, 1.04–2.33, quadratic P = 0.001).
The updated BMI analyses yielded attenuated results in
men (all trend P > 0.05) but not in women where a positive
linear association with lacunar (trend P < 0.001) and large-artery
occlusive strokes (trend P = 0.03), and a reverse J-shaped
association with cardioembolic stroke (quadratic P = 0.002) were
found. The associations of BMI ≥30 kg=m2 for lacunar and large-
artery occlusive strokes (HR 2.32; 95% CI, 1.49–3.61 and HR
Li Y, et al.
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Table 1. Means and proportions of updated lifestyle and medical histories according to categories of cumulative average body mass
index
Body mass index, kg=m2 P for
diﬀerencea<19 19–<21 21–<23 23–<25 25–<27 27–<30 ≥30
Men
Number 1,712 5,753 11,007 11,989 7,342 3,720 820
Age at baseline, years, mean (standard deviation) 54.1 (8.8) 52.7 (8.3) 52.1 (7.9) 51.4 (7.6) 50.8 (7.4) 50.5 (7.2) 50.1 (7.3) <0.001
Age distribution, % <0.001
40–44 19.3 21.9 22.0 23.2 25.4 25.8 29.9
45–49 14.9 17.0 19.3 20.9 20.9 21.9 21.6
50–54 15.1 17.8 19.0 20.6 21.1 21.5 18.7
55–59 21.5 22.0 21.6 20.4 20.0 19.5 18.3
60–64 12.0 10.7 9.7 8.5 7.8 7.2 8.3
65–69 17.1 10.7 8.4 6.5 4.8 4.2 3.3
Smoking, % <0.001
Never-smoker 14.4 16.1 20.2 23.1 26.9 27.9 28.5
Ex-smoker 29.0 30.9 33.4 37.1 37.1 36.5 34.2
<20 cigarettes=day 22.3 17.7 14.5 11.0 9.6 7.4 7.3
≥20 cigarettes=day 34.3 35.4 31.9 28.8 26.4 28.2 30.0
Alcohol consumption, % <0.001
Never-drinker 40.0 35.0 33.5 33.9 35.1 37.2 39.8
Former-drinker 6.0 4.8 4.2 3.7 3.9 4.0 3.8
<150 g=week 10.9 11.3 10.7 11.2 11.0 10.7 11.7
150–<300g=week 18.5 20.9 22.3 22.5 21.8 21.1 17.8
≥300 g=week 24.7 28.0 29.2 28.6 28.2 27.0 27.0
Leisure-time physical activity, % <0.001
None 62.8 59.7 55.7 53.7 52.5 53.9 58.2
1–3 times=month 14.0 16.3 18.9 20.0 20.6 21.1 19.4
1–2 times=week 10.3 10.6 12.0 12.7 12.6 11.6 10.7
3–4 times=week 6.3 6.5 6.6 6.9 7.8 7.3 6.2
Almost everyday 6.7 7.0 6.7 6.7 6.6 6.1 5.5
History of hypertension, % 22.0 25.5 29.5 34.7 39.6 45.3 49.9 <0.001
History of dyslipidemia, % 9.8 8.6 9.2 10.7 11.1 13.2 17.4 <0.001
History of diabetes mellitus, % 3.7 4.5 6.9 9.2 11.8 12.3 14.5 <0.001
Women
Number 2,306 6,796 11,996 11,742 7,572 4,546 1,455
Age at baseline, years, mean (standard deviation) 52.9 (8.7) 51.5 (8.3) 51.8 (8.0) 52.1 (7.7) 52.7 (7.7) 52.7 (7.6) 52.7 (7.6) <0.001
Age distribution, % <0.001
40–44 22.3 26.5 23.4 20.6 18.4 18.1 18.4
45–49 17.1 19.4 20.1 19.9 18.2 17.7 18.7
50–54 18.5 17.9 19.5 21.6 21.3 22.2 22.1
55–59 17.5 17.5 19.2 21.0 23.0 23.4 21.8
60–64 10.6 9.1 9.5 9.3 10.7 10.8 10.9
65–69 14.1 9.6 8.2 7.7 8.3 7.8 8.3
Smoking, % <0.001
Never-smoker 86.5 90.2 92.1 93.1 92.5 91.5 88.7
Ex-smoker 4.7 3.2 3.0 2.9 3.4 4.0 4.5
<20 cigarettes=day 5.9 4.4 3.4 2.4 2.6 2.6 3.8
≥20 cigarettes=day 3.0 2.2 1.5 1.6 1.5 1.9 3.1
Alcohol consumption, % <0.001
Never-drinker 87.9 85.8 87.2 88.7 89.9 91.6 92.0
Former-drinker 0.6 0.6 0.7 0.6 0.5 0.7 0.9
<150 g=week 7.1 9.2 8.4 7.5 6.4 5.2 4.3
150–<300g=week 2.9 3.1 2.6 2.2 2.5 1.5 1.4
≥300 g=week 1.5 1.3 1.1 1.0 0.8 1.1 1.3
Leisure-time physical activity, % <0.001
None 54.9 57.1 54.8 55.8 65.1 59.1 62.4
1–3 times=month 14.3 13.4 14.3 14.8 11.0 12.5 12.0
1–2 times=week 13.7 13.4 14.4 13.2 10.8 12.4 10.7
3–4 times=week 9.2 8.0 8.4 8.6 7.0 7.9 7.2
Almost everyday 7.8 8.2 8.1 7.6 6.2 8.1 7.7
History of hypertension, % 20.7 23.2 28.4 36.1 44.2 51.7 58.6 <0.001
History of dyslipidemia, % 9.3 12.0 14.5 17.9 20.1 22.8 21.6 <0.001
History of diabetes mellitus, % 3.9 3.6 4.4 5.2 6.9 9.6 13.8 <0.001
aAnalysis of variance for continuous variables, and Chi-square test for categorical variables.
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2.51; 95% CI, 1.31–4.81, respectively) as well as that of BMI
<19.0 kg=m2 for cardioembolic stroke (HR 2.10; 95% CI,
1.20–3.68) were more evident compared to the ﬁndings obtained
by cumulative average or baseline BMI analyses (eTable 2).
The sensitivity analyses that regarded undetermined ischemic
stroke as lacunar, large-artery occlusive, or cardioembolic
strokes, respectively, did not materially change the results (data
not shown in table).
DISCUSSION
In the present prospective study, cumulative average BMI showed
a linear and a positive eﬀect on sub-distribution hazard of
ischemic stroke across all the subtypes in both sexes except for
cardioembolic stroke in women. Compared to persons with BMI
of 23–<25kg=m2, men with BMI ≥30 kg=m2 had 2.1-times
higher risk of cardioembolic stroke, and women with BMI ≥30
kg=m2 had 1.8- to 1.9-times higher risks of lacunar, large-artery
occlusive, and cardioembolic strokes. Women with BMI of
27–<30kg=m2 had also 1.4-times higher risk of lacunar stroke.
These associations were independent of known confounders or
mediators, including age, smoking, alcohol consumption, leisure-
time physical activity, and histories of hypertension, dyslipide-
mia, and diabetes mellitus. Linear associations of cumulative
average BMI with all ischemic stroke subtypes in men would
indicate the existence of no speciﬁc cut-points, which implies the
importance of preventing a rise in weight in the population for the
prevention of ischemic stroke.
We have previously reported a linear positive relation of
BMI with the incidence of ischemic stroke only in women in the
JPHC Study, with a median follow-up of 7.9 years.20 In the
present study of extended follow-up with a median of 20.0 years,
which focused on ischemic stroke subtypes, we found signiﬁcant
relations of cumulative average BMI with all ischemic stroke
subtypes in men. This may be due to increased statistical power,
with more cases included in the present study (n = 1,181
ischemic stroke cases for the previous analysis and n = 1,772
for the present analysis).
Table 2. Sub-distribution hazard ratios and 95% conﬁdence intervals of incident ischemic stroke subtypes according to categories of
cumulative average body mass index
Body mass index (kg=m2)
Trend Pc
<19 19–<21 21–<23 23–<25 25–<27 27–<30 ≥30
Men person-years 26,828 98,343 194,892 216,690 132,878 66,352 13,798
Lacunar stroke
Number of incidents 23 126 196 219 145 78 22
Incidence rate 0.86 1.28 1.01 1.01 1.09 1.18 1.59
Multivariable SHR1 (95% CI)b 0.63 (0.41–0.98) 1.10 (0.89–1.38) 0.92 (0.76–1.12) 1 1.14 (0.92–1.40) 1.24 (0.95–1.60) 1.70 (1.09–2.64) 0.003
Multivariable SHR2 (95% CI)b 0.58 (0.38–0.90) 1.03 (0.83–1.29) 0.89 (0.74–1.08) 1 1.16 (0.94–1.44) 1.26 (0.97–1.63) 1.68 (1.08–2.62) <0.001
Multivariable SHR3 (95% CI)b 0.62 (0.40–0.96) 1.09 (0.87–1.36) 0.93 (0.77–1.13) 1 1.14 (0.93–1.41) 1.18 (0.91–1.54) 1.51 (0.96–2.35) 0.007
Large-artery occlusive stroke
Number of incidents 7 50 98 127 59 44 10
Incidence rate 0.26 0.51 0.50 0.59 0.44 0.66 0.72
Multivariable SHR1 (95% CI)b 0.32 (0.15–0.69) 0.75 (0.54–1.04) 0.79 (0.61–1.03) 1 0.80 (0.59–1.09) 1.22 (0.86–1.71) 1.37 (0.71–2.63) <0.001
Multivariable SHR2 (95% CI)b 0.30 (0.14–0.63) 0.69 (0.50–0.97) 0.76 (0.58–0.99) 1 0.83 (0.61–1.13) 1.23 (0.88–1.74) 1.34 (0.70–2.56) <0.001
Multivariable SHR3 (95% CI)b 0.32 (0.15–0.70) 0.74 (0.53–1.04) 0.80 (0.61–1.05) 1 0.80 (0.59–1.09) 1.15 (0.82–1.61) 1.18 (0.61–2.27) 0.002
Cardioembolic stroke
Number of incidents 18 63 145 155 113 54 20
Incidence rate 0.67 0.64 0.74 0.72 0.85 0.81 1.45
Multivariable SHR1 (95% CI)b 0.62 (0.38–1.02) 0.73 (0.54–0.98) 0.93 (0.74–1.17) 1 1.29 (1.01–1.64) 1.27 (0.94–1.73) 2.39 (1.50–3.80) <0.001
Multivariable SHR2 (95% CI)b 0.60 (0.37–0.99) 0.71 (0.52–0.95) 0.92 (0.73–1.15) 1 1.30 (1.02–1.66) 1.29 (0.95–1.76) 2.36 (1.48–3.77) <0.001
Multivariable SHR3 (95% CI)b 0.66 (0.40–1.08) 0.75 (0.56–1.01) 0.96 (0.76–1.20) 1 1.27 (1.00–1.62) 1.21 (0.89–1.65) 2.14 (1.34–3.41) <0.001
Women person-years 40,758 127,795 228,983 226,509 145,671 86,667 27,263
Lacunar stroke
Number of incidents 16 52 92 127 83 78 33
Incidence rate 0.39 0.41 0.40 0.56 0.57 0.90 1.21
Multivariable SHR1 (95% CI)b 0.57 (0.34–0.96) 0.71 (0.52–0.98) 0.72 (0.55–0.94) 1 0.97 (0.74–1.28) 1.55 (1.17–2.05) 2.14 (1.45–3.16) <0.001
Multivariable SHR2 (95% CI)b 0.55 (0.32–0.92) 0.71 (0.51–0.98) 0.72 (0.55–0.94) 1 0.97 (0.74–1.28) 1.53 (1.15–2.03) 2.08 (1.41–3.07) <0.001
Multivariable SHR3 (95% CI)b 0.60 (0.35–1.01) 0.75 (0.55–1.04) 0.74 (0.57–0.97) 1 0.94 (0.71–1.24) 1.40 (1.05–1.87) 1.77 (1.19–2.63) <0.001
Large-artery occlusive stroke
Number of incidents 9 21 46 54 40 32 16
Incidence rate 0.22 0.16 0.20 0.24 0.27 0.37 0.59
Multivariable SHR1 (95% CI)b 0.79 (0.39–1.62) 0.70 (0.42–1.16) 0.85 (0.58–1.27) 1 1.06 (0.70–1.59) 1.40 (0.90–2.17) 2.21 (1.26–3.88) <0.001
Multivariable SHR2 (95% CI)b 0.74 (0.36–1.52) 0.68 (0.41–1.13) 0.85 (0.57–1.26) 1 1.06 (0.70–1.59) 1.37 (0.89–2.13) 2.12 (1.20–3.72) <0.001
Multivariable SHR3 (95% CI)b 0.81 (0.40–1.65) 0.73 (0.44–1.21) 0.88 (0.59–1.30) 1 1.02 (0.68–1.54) 1.29 (0.83–2.01) 1.90 (1.07–3.37) 0.003
Cardioembolic stroke
Number of incidents 17 39 65 70 41 45 21
Incidence rate 0.42 0.31 0.28 0.31 0.28 0.52 0.77
Multivariable SHR1 (95% CI)b 1.10 (0.65–1.87) 0.97 (0.65–1.43) 0.92 (0.66–1.29) 1 0.85 (0.58–1.25) 1.58 (1.09–2.30) 2.31 (1.41–3.79) 0.006
Multivariable SHR2 (95% CI)b 1.09 (0.64–1.85) 0.97 (0.66–1.44) 0.92 (0.66–1.29) 1 0.85 (0.58–1.25) 1.57 (1.08–2.28) 2.27 (1.38–3.72) 0.007
Multivariable SHR3 (95% CI)b 1.24 (0.73–2.12) 1.07 (0.72–1.59) 0.97 (0.69–1.37) 1 0.81 (0.55–1.18) 1.42 (0.97–2.06) 1.89 (1.15–3.11) 0.14
CI, conﬁdence interval; SHR, sub-distribution hazard ratio.
aCrude incidence rate were expressed as rate per 1,000 person-years.
bMultivariable SHR1: adjusted for baseline age. Multivariable SHR2: adjusted further for updated smoking, alcohol consumption and leisure-time physical
activity. Multivariable SHR3: adjusted further for updated histories of hypertension, dyslipidemia and diabetes mellitus.
cMedian values of cumulative average body mass index in each categories were used for test of a linear trend across categories.
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Few studies have addressed the association between the degree
of obesity and risks of ischemic stroke subtypes.5,6 Our results
derived from a relatively lean population (mean baseline BMI:
23.5 kg=m2) is primarily consistent with that from a previous study
of an American population (mean BMI: 27.8 kg=m2), which found
BMI quintiles were linearly positively associated with risks of
lacunar, non-lacunar, and cardioembolic strokes.5 However, the
associations in that study were explained by possible mediators,
such as measured systolic blood pressure. Another prospective
study of Japanese that updated BMI up to ﬁve times with those
obtained during follow-up examinations reported that the only
signiﬁcant ﬁnding was for lacunar stroke incidence in women.6
That ﬁnding might be consistent with the present analysis that
simply updated BMI: the signiﬁcant associations related to BMI
≥30 kg=m2 were found only in women for lacunar and large-artery
occlusive strokes. Direct comparison with the ARIC Study
regarding possible mediation would be hard since mediators,
such as measured systolic blood pressure, total cholesterol, or
glucose intolerance, were used in the former, while the majority
of the present participants only had self-reported histories of
hypertension, dyslipidemia, and diabetes mellitus. Nevertheless,
we should consider that residual confounding (mediation) would
be likely in the analyses where only self-reported histories were
adjusted. However, if the association existed between BMI and
ischemic stroke subtypes, independent of known mediators,
possible explanations would include insulin resistance, endothelial
dysfunction, or a low-grade chronic inﬂammation state.21,22 In any
case, the present study suggests the importance of weight control
for the prevention of all ischemic stroke subtypes.
The excess risks of lacunar and large-artery occlusive strokes
for BMI ≥30 kg=m2 category compared to the reference category
(23–<25 kg=m2) seemed more evident in women than in men.
This might be due to some unmeasured stroke risk factors that
are reportedly more strongly related to obesity in women than
in men, such as low-grade systematic inﬂammation23,24 and
prothrombotic factors.25 In any case, the present results imply that
avoidance of obesity oﬀers the potential of reducing lacunar and
large-artery occlusive strokes in women.
The updated BMI analysis showed that the risk of
cardioembolic stroke for the lowest BMI category with
cardioembolic stroke was signiﬁcantly elevated in women. This
ﬁnding might correspond to a U-shaped association reported
between BMI and atrial ﬁbrillation,26 the most important risk
factor for cardioembolic stroke.27,28 Furthermore, low body weight
was reportedly a signiﬁcant risk factor for stroke incidence in male
and female Japanese patients with atrial ﬁbrillation.29 Further
studies that obtained atrial ﬁbrillation as well as use of antiplatelet
medication, which may modify the association of atrial ﬁbrillation
with risk of cardioembolic stroke30 are warranted.
The stratiﬁed analyses by hypertension yielded somewhat
puzzling results: the lack of association between cumulative
average BMI and risk of large-artery occlusive stroke in men with
hypertension and in women without hypertension. The lack of the
association in men with hypertension may be due to the higher
probability of treatment for dyslipidemia and diabetes in the
higher categories of BMI by local physicians.31,32 This tendency
might have contributed to the prevention of large-artery occlusive
stroke because dyslipidemia and diabetes, as well as hyper-
tension, are major risk factors for this stroke subtype.33,34 Another
reason for the lack of that association might be related to the fact
that hypertension is the single strongest risk factor for large-artery
occlusive infarction, the impact of BMI could be masked and not
be properly evaluated in men with hypertension. In women
without hypertension, the lack of the association between
cumulative average BMI and risk of large-artery occlusive stroke
might merely be by chance, probably because the number of
large-artery occlusive stroke cases was small.
Simply speaking, the analyses that only used baseline or
updated BMI produced attenuated results, which implies that
cumulative average BMI captured important and relevant aspect
of long-term eﬀect of BMI on the sub-distribution hazard of
ischemic stroke subtypes better than single-point measures.
However, this was not true for women. The increased risk of
cardioembolic stroke observed for women with BMI ≥30 kg=m2
as well as for those with 19–<21kg=m2 were more apparent in
the baseline BMI analysis compared to the cumulative average
BMI analysis. In addition, the associations of BMI ≥30 kg=m2
with risks of lacunar and large-artery occlusive strokes, as well as
the association of BMI <19 kg=m2 with risk of cardioembolic
stroke, were more evident in the updated BMI analysis compared
to the cumulative average BMI analysis. Women might be more
susceptible to a short-term eﬀect of BMI, which is indicated
by the fact that women gain weight with aging on average.35
The strengths of the present study include valid identiﬁcation
of suﬃcient numbers of incident ischemic stroke subtypes that
enabled us to conduct sex-speciﬁc analyses or stratiﬁed analyses
by hypertension. Moreover, we examined three BMI variables in
relation to ischemic stroke subtype risks, somewhat diﬀerent
results of which would aid better comparisons among studies.
Also, we took competing risk of death into account to obtain
more accurate estimates of the associations.
The present study has potential limitations. First, BMI was
calculated from self-reported body weight and height. Although
the validity of self-reported height and body weight has been
reported,36,37 overweight or obese subjects underestimated their
body weight and underweight subjects overestimated their body
weight,38 which would be related to attenuation of the observed
associations. Second, the information about atrial ﬁbrillation was
not available. Although inconsistencies exist in the literature,39–41
low as well as high BMI were reportedly associated with high risk
of atrial ﬁbrillation.41,42 The present reverse J-shaped association
of BMI with cardioembolic stroke risk might have been partly
explained via atrial ﬁbrillation. However, the adjustment for self-
reported arrhythmia or the exclusion of those with self-reported
arrhythmia did not materially change the reverse J-shaped
association. Third, we were unable to evaluate to what extent
the observed association was mediated through measured blood
pressure or blood levels of glucose and lipids, since less than
25% subjects had complete data. Previous studies in Western
populations have reported that these mediators alone or together
entirely explained the eﬀect of BMI on incident lacunar,
nonlacunar, and cardioembolic stroke.5 Further studies in East
Asian population are needed to clarify whether the signiﬁcant
association found in the present study would be explained via
those measured potential mediators.
In conclusion, cumulative average BMI showed a positive
linear eﬀect on sub-distribution hazards of lacunar, large-artery
occlusive, and cardioembolic strokes in both sexes, except for
cardioembolic stroke in women. There were approximately two-
fold excess risk of cardioembolic stroke in both sexes and of
lacunar and large-artery occlusive strokes in women for BMI
≥30 kg=m2 compared to BMI 23–<25 kg=m2.
Li Y, et al.
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